// App-Quantinova.ai

BSH19‐PO‐158 : Incidences of thrombosis, major bleeding and 30‐day mortality in patients receiving veno‐venous extracorporeal membrane oxygenation and value of laboratory parameters at presentation in predicting outcomes

Researchers

Presenter

  • D. Jayakody Arachchillage

Principal Investigators

  • S. Khanna

  • M. Passariello

  • W. Banya

  • M. Laffan

  • S. Ledot

Medical Centers

  • Department of Haematology, Royal Brompton Hospital

  • Department of Histopathology, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Collagen type IV alpha 2 chain

  • Creatinine

  • Activated partial thromboplastin time

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved